aztreonam has been researched along with Lung Neoplasms in 2 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Lung Neoplasms: Tumors or cancer of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aztreonam was then discontinued and the patient was treated with supportive measures and steroids and his renal failure reversed over the course of 5 days." | 5.27 | Acute renal failure, skin rash, and eosinophilia associated with aztreonam. ( Pazmiño, P, 1988) |
| "Aztreonam was then discontinued and the patient was treated with supportive measures and steroids and his renal failure reversed over the course of 5 days." | 1.27 | Acute renal failure, skin rash, and eosinophilia associated with aztreonam. ( Pazmiño, P, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miglioli, PA | 1 |
| Pivetta, P | 1 |
| Fantoni, U | 1 |
| Pazmiño, P | 1 |
2 other studies available for aztreonam and Lung Neoplasms
| Article | Year |
|---|---|
Effect of method of antibiotic administration on pleural exudate penetration: a study of aztreonam given by rapid injection and constant infusion.
Topics: Aged; Anti-Bacterial Agents; Aztreonam; Exudates and Transudates; Humans; Infusions, Intravenous; In | 1989 |
Acute renal failure, skin rash, and eosinophilia associated with aztreonam.
Topics: Acute Kidney Injury; Aged; Aztreonam; Combined Modality Therapy; Drug Eruptions; Eosinophilia; Human | 1988 |